Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - naloxone hydrochloride dihydrate -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - naloxone hydrochloride dihydrate -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - naloxone hydrochloride dihydrate, quantity: 440 microgram (equivalent: naloxone hydrochloride?, qty 400 microgram) - injection - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; edetate sodium - naloxone is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, codeine, morphine and heroin, and the mixed opioid agonist-antagonist analgesics such as pentazocine. naloxone is also indicated for the diagnosis of suspected acute opioid overdosage.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

southern xp ip pty ltd - naloxone hydrochloride dihydrate, quantity: 440 microgram (equivalent: naloxone hydrochloride?, qty 400 microgram) - injection - excipient ingredients: water for injections; hydrochloric acid; sodium chloride; edetate sodium - naloxone is indicated for the complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids including propoxyphene, methadone, codeine, morphine and heroin, and the mixed opioid agonist-antagonist analgesics such as pentazocine. naloxone is also indicated for the diagnosis of suspected acute opioid overdosage.

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - naloxone hydrochloride - solution for injection/infusion - 400 microgram(s)/millilitre - antidotes; naloxone

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

international medication systems (uk) ltd - naloxone hydrochloride - solution for injection - 400 microgram(s)/millilitre - antidotes; naloxone

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

indivior pty ltd - buprenorphine hydrochloride, quantity: 2.16 mg (equivalent: buprenorphine, qty 2 mg); naloxone hydrochloride dihydrate, quantity: 0.61 mg (equivalent: naloxone, qty 0.5 mg) - soluble film - excipient ingredients: sunset yellow fcf; polyethylene oxide; hypromellose; maltitol; citric acid; acesulfame potassium; sodium citrate; titanium dioxide; propylene glycol; purified water; industrial methylated spirit; flavour - for the treatment of opiate dependence within a framework of medical, social, and psychological treatment.

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

dlrc pharma services limited - naloxone hydrochloride - solution for injection - 400 microgram(s)/millilitre - antidotes; naloxone

Kanada - angličtina - Health Canada

omega laboratories limited - naloxone hydrochloride (naloxone hydrochloride dihydrate) - solution - 0.4mg - naloxone hydrochloride (naloxone hydrochloride dihydrate) 0.4mg - opiate antagonists

Kanada - angličtina - Health Canada

omega laboratories limited - naloxone hydrochloride (naloxone hydrochloride dihydrate) - solution - 1mg - naloxone hydrochloride (naloxone hydrochloride dihydrate) 1mg - opiate antagonists